Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,410 | -27,937 | -119,721 | -92,295 | -64,403 |
| Depreciation Amortization | 1,227 | 567 | 1,087 | 568 | 290 |
| Accounts receivable | -1,242 | 267 | 268 | -1,857 | -345 |
| Accounts payable and accrued liabilities | -3,399 | -2,290 | 1,017 | -1,880 | -2,192 |
| Other Working Capital | -15,677 | -9,806 | -33,632 | -21,822 | -17,304 |
| Other Operating Activity | 12,240 | 5,780 | 18,514 | 15,082 | 12,798 |
| Operating Cash Flow | $-59,261 | $-33,419 | $-132,467 | $-102,204 | $-71,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -2,596 | -1,970 | -1,763 |
| Purchase Of Investment | -70,851 | -43,441 | -133,929 | -121,426 | -114,790 |
| Sale Of Investment | 94,357 | 51,556 | 261,971 | 201,418 | 159,687 |
| Investing Cash Flow | $23,492 | $8,101 | $125,446 | $78,022 | $43,134 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,238 | 3,332 | 816 | 680 | 595 |
| Financing Cash Flow | $6,238 | $3,332 | $816 | $680 | $595 |
| Beginning Cash Position | 68,036 | 68,036 | 74,241 | 74,241 | 74,241 |
| End Cash Position | 38,505 | 46,050 | 68,036 | 50,739 | 46,814 |
| Net Cash Flow | $-29,531 | $-21,986 | $-6,205 | $-23,502 | $-27,427 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,261 | -33,419 | -132,467 | -102,204 | -71,156 |
| Capital Expenditure | -14 | -14 | -2,596 | -1,970 | -1,763 |
| Free Cash Flow | -59,275 | -33,433 | -135,063 | -104,174 | -72,919 |